AstraZeneca announces 'robust' results from anti-Covid drug trial

AstraZeneca announces 'robust' results from anti-Covid drug trial

LONDON: Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based Covid-19 drug had shown robust efficacy and long-term prevention.

© New Straits Times Press (M) Bhd

Scroll to Top